AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glimbite-MV2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Pure and Cure Healthcare Private Limited

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glimbite-MV2 Tablet SR

Diabexe-Duo SR tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabexe-Duo SR should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose levels, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. The most prevalent adverse effect of Diabexe-Duo SR is hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms, such as sweating, lightheadedness, headache, and tremors, and know how to address them. Consistent mealtimes and carrying a readily available fast-acting glucose source, like sugary snacks or juice, are essential preventative measures. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring is necessary, and your doctor may recommend blood tests to assess blood cell counts and liver function.

Uses of Glimbite-MV2 Tablet SR

Managing Type 2 Diabetes

Major Benefits of Glimbite-MV2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glimbite-MV2 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

Common Side effects of Glimbite-MV2 Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimbite-MV2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Glimbite-MV2 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

How Glimbite-MV2 Tablet SR works:

Extended-release Glimbite-MV2 tablets contain a triple-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimbite-MV2 Tablet SR and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimbite-MV2 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Glimbite-MV2 Tablet SR while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

The use of Glimbite-MV2 Tablet SR is contraindicated in patients with renal impairment and should be avoided. Individuals with severe kidney disease should not take Glimbite-MV2 Tablet SR. Medical advice is recommended.

LiverLiverCAUTION

Exercise caution when prescribing Glimbite-MV2 Tablet SR to individuals with hepatic impairment. Dosage modification of Glimbite-MV2 Tablet SR may be necessary. Physician consultation is advised. A reduced initial dose of Glimbite-MV2 Tablet SR is typically employed in patients exhibiting mild to moderate liver dysfunction; however, its administration is contraindicated in those with severe liver disease.

What if you forget to take Glimbite-MV2 Tablet SR :

Should you forget a dose of Glimbite-MV2 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimbite-MV2 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Glimbite-MV2 Tablet SR

Glimbite-MV2 Tablet SR combines glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose levels. This medication is not suitable for type 1 diabetes.
Glimbite-MV2 Tablet SR may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, altered taste, gas, stomach pain, headache, rash, and respiratory infection.
Glimbite-MV2 Tablet SR is contraindicated in patients with known allergies to its components or excipients, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Glimbite-MV2 Tablet SR and alcohol is unsafe. This combination may worsen low blood sugar and raise the risk of lactic acidosis.
Glimbite-MV2 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container as directed on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Glimbite-MV2 Tablet SR
145
MRP 177
18% off